Halozyme Therapeutics (HALO) Withdraws Proposal to Acquire Evotec (EVO) Following Evotec's Unwillingness to Engage in Discussions Nov 22, 2024 08:35AM
Halozyme Therapeutics (HALO) Provides Update on Non-Binding Proposal to Combine with Evotec (EVO) Nov 18, 2024 07:03AM
Halozyme Therapeutics (HALO) Confirms Proposal to Combine with Evotec (EVO) for €11.00 Per Share in an All-Cash Transaction Nov 14, 2024 04:16PM